Incidence of diabetes mellitus at postpartum six to twelve months following the diagnosis of gestational diabetes mellitus

Kerimoğlu, Özlem Seçilmiş; Yalvaç, Serdar; Karçaaltİnçaba, Deniz; Kandemir, Ömer
June 2010
Journal of the Turkish-German Gynecological Association;Jun2010, Vol. 11 Issue 2, p89
Academic Journal
Objective: The aim of this study was to research the rates of diabetes mellitus (DM) and the risk factors that may play a role in the prediction of this condition by evaluating patients with the diagnosis of gestational diabetes mellitus (GDM) at the 6th-12th postpartum months. Material and Method: Among 109 cases who had been invited to the hospital for oral glucose tolerance test (OGTT) at the 6th-12th postpartum months, 84 cases (77%) were enrolled in the study. To the 78 patients that were found to be appropriate according to the study criteria, 75 gr OGTT was administered. Patients who had new pregnancies during the period of postpartum screening, and those with previously diagnosed DM were excluded from the study. Results: While the results of 23 cases (29.5%) included in the study were normal, 27 cases (34.6%) were diagnosed with DM and 28 cases (35.9%) were diagnosed as having an impaired glucose tolerance and /or impaired fasting glucose (IGT/IFG). Among patients diagnosed with DM, the history of DM in the first degree relatives (n=21, 77.8%, p=0.018), body mass index before pregnancy (mean=30.1±4.4, p=0.009) and insulin requirement for the treatment of GDM (n=25, 92.6%, p<0.05) were determined at higher rates. In the logistic regression analysis, multiparity (OR=2) and insulin requirement during pregnancy (OR: 7.27) were found to be the predictive factors in the development of postpartum DM. Discussion: In this study, the determination of high rates of DM development in the postpartum period after GDM demonstrates the necessity of augmentation in efforts to increase the screening rates after delivery and to increase the patients' acknowledgement of this topic.


Related Articles

  • Impaired Glucose Tolerance, but not Impaired Fasting Glucose, Is Associated With Increased Levels of Coronary Heart Disease Risk Factors. Blake, Deirdre R.; Meigs, James B.; Muller, Denis C.; Najjar, Samer S.; Andres, Reubin; Nathan, David M. // Diabetes;Aug2004, Vol. 53 Issue 8, p2095 

    Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) identify individuals at high risk for progression to diabetes. Whether IFG and IGT have comparable coronary heart disease (CHD) risk factor profiles, independent of their progression to diabetes, is unclear. We determined CHD...

  • Hemoglobin A1c, Fasting Glucose, and Cardiovascular Risk in a Population With High Prevalence of Diabetes. HONG WANG; SHARA, NAWAR M.; LEE, ELISA T.; DEVEREUX, RICHARD; CALHOUN, DARREN; DE SIMONE, GIOVANNI; UMANS, JASON G.; HOWARD, BARBARA V. // Diabetes Care;Sep2011, Vol. 34 Issue 9, p1952 

    OBJECTIVE--We compared A1C and fasting plasma glucose (FPG) in predicting cardiovascular disease (CVD) in a population with widespread obesity and diabetes. RESEARCH DESIGN AND METHODS--A total of 4,549 American Indian adults underwent the Strong Heart Study (SHS) baseline examination...

  • (D) BLOOD GLUCOSE AND DIABETES.  // Heart;Dec2005 Supplement 5, Vol. 91, pv40 

    The article focuses on the continuous relationship between blood glucose and the overall cardiovascular disease (CVD) risk in people with diabetes mellitus. The traditional assessment of glycemia has been evaluated with an oral glucose tolerance test which categorizes individuals into four...

  • K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years. Alvarsson, M.; Wajngot, A.; Cerasi, E.; Efendic, S. // Diabetologia;Nov2005, Vol. 48 Issue 11, p2262 

    Aims/hypothesis: Insulin resistance and insulin deficiency are proposed as risk factors for IGT and type 2 diabetes. We assessed the predictive value of initial parameters for the outcome of an OGTT performed 24.3±2.9 years later in an unselected healthy non-obese population. Methods: The...

  • A Risk Score for Type 1 Diabetes Derived from Participants in the Diabetes Prevention Trial-Type 1 (DPT-1). Sosenko, Jay M.; Krischer, Jeffrey P.; Palmer, Jerry P.; Mahon, Jeffrey; Cowie, Catherine; Greenbaum, Carla J.; Cuthbertson, David D.; Lachin, John; Skyler, Jay S. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA55 

    A risk score that is not dependent on intravenous glucose tolerance tests (IVGTTs) was developed for predicting type 1 diabetes (T1D) from those participating in the parenteral and oral insulin DPT-1 trials (n=670), all islet-cell autoantibody (ICA) positive relatives of T1D patients. There was...

  • Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria. Di Pino, Antonino; Scicali, Roberto; Calanna, Salvatore; Urbano, Francesca; Mantegna, Concetta; Rabuazzo, Agata Maria; Purrello, Francesco; Piro, Salvatore // Diabetes Care;May2014, Vol. 37 Issue 5, p1447 

    OBJECTIVE We investigated the cardiovascular risk pro le in subjects with prediabetes and new-onset type 2 diabetes identified by glycated hemoglobin A1c (HbA1c) according to the new American Diabetes Association criteria. RESEARCH DESIGN AND METHODS Arterial stiffness, intima-media thickness...

  • Reciprocal Association of Plasma IGF-1 and Interleukin-6 Levels With Cardiometabolic Risk Factors in Nondiabetic Subjects. Succurro, Elena; Andreozzi, Francesco; Sciaqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio // Diabetes Care;Sep2008, Vol. 31 Issue 9, p1886 

    OBJECTIVE -- To examine the relationship between plasma IGF-1 and interleukin-6 (IL-6) levels in Caucasian nondiabetic subjects and evaluate the association of IGF-1 and IL-6 with the cardiometabolic risk factors characterizing metabolic syndrome (MetS). RESEARCH DESIGN AND METHODS -- The study...

  • Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care. Cabré, Joan-Josep; Martín, Francisco; Costa, Bernardo; Piñol, Josep L.; Llor, Josep L.; Ortega, Yolanda; Basora, Josep; Baldrich, Marta; Solà, Rosa; Daniel, Jordi; Hernández, Josep Ma; Saumell, Judit; Bladé, Jordi; Sagarra, Ramon; Basora, Teresa; Montañés, Dolors; Frigola, Joan L.; Donado-Mazarrón, Angel; García-Vidal, Maria Teresa; Sánchez-Oro, Isabel // BMC Public Health;2008, Vol. 8 Issue 1, p251 

    To estimate the prevalence of metabolic syndrome (MS) in a population receiving attention in primary care centers (PCC) we selected a random cohort of ostensibly normal subjects from the registers of 5 basic-health area (BHA) PCC. Diagnosis of MS was with the WHO, NCEP and IDF criteria....

  • Body and Liver Fat Mass Rather Than Muscle Mitochondrial Function Determine Glucose Metabolism in Women With a History of Gestational Diabetes Mellitus. PRIKOSZOVICH, THOMAS; WINZER, CHRISTINE; SCHMID, ALBRECHT INGO; SZENDROEDI, JULIA; CHMELIK, MAREK; PACINI, GIOVANNI; KRŠŠÁK, MARTIN; MOSER, EWALD; FUNAHASHI, TOHRU; WALDHÄUSL, WERNER; KAUTZKY-WILLER, ALEXANDRA; RODEN, MICHAEL // Diabetes Care;Feb2011, Vol. 34 Issue 2, p430 

    OBJECTIVE--Ectopic lipid storage in muscle (intramyocellular lipids [IMCL]) and liver (hepatocellular lipids [HCL]) coexists with impaired myocellular flux through ATP synthase (fATPase) in certain cohorts with increased risk of type 2 diabetes. Because women with a history of gestational...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics